125 related articles for article (PubMed ID: 10514077)
1. Recombinant expression, purification, and characterization of Toxoplasma gondii adenosine kinase.
Darling JA; Sullivan WJ; Carter D; Ullman B; Roos DS
Mol Biochem Parasitol; 1999 Sep; 103(1):15-23. PubMed ID: 10514077
[TBL] [Abstract][Full Text] [Related]
2. Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus.
Sullivan WJ; Chiang CW; Wilson CM; Naguib FN; el Kouni MH; Donald RG; Roos DS
Mol Biochem Parasitol; 1999 Sep; 103(1):1-14. PubMed ID: 10514076
[TBL] [Abstract][Full Text] [Related]
3. Adenosine kinase from Cryptosporidium parvum.
Galazka J; Striepen B; Ullman B
Mol Biochem Parasitol; 2006 Oct; 149(2):223-30. PubMed ID: 16879885
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii adenosine kinase: expression, purification, characterization, crystallization and preliminary crystallographic analysis.
Recacha R; Talalaev A; DeLucas LJ; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2000 Jan; 56(Pt 1):76-8. PubMed ID: 10666633
[TBL] [Abstract][Full Text] [Related]
5. 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; el Kouni MH
Biochem Pharmacol; 2008 Oct; 76(8):958-66. PubMed ID: 18755159
[TBL] [Abstract][Full Text] [Related]
6. The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression.
Chiang CW; Carter N; Sullivan WJ; Donald RG; Roos DS; Naguib FN; el Kouni MH; Ullman B; Wilson CM
J Biol Chem; 1999 Dec; 274(49):35255-61. PubMed ID: 10575012
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and characterization of recombinant Saccharomyces cerevisiae adenosine kinase.
Lu XB; Wu HZ; Ye J; Fan Y; Zhang HZ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):666-70. PubMed ID: 12883639
[TBL] [Abstract][Full Text] [Related]
8. Purine salvage pathways in the apicomplexan parasite Toxoplasma gondii.
Chaudhary K; Darling JA; Fohl LM; Sullivan WJ; Donald RG; Pfefferkorn ER; Ullman B; Roos DS
J Biol Chem; 2004 Jul; 279(30):31221-7. PubMed ID: 15140885
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii.
Iltzsch MH; Uber SS; Tankersley KO; el Kouni MH
Biochem Pharmacol; 1995 May; 49(10):1501-12. PubMed ID: 7763293
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding.
Schumacher MA; Scott DM; Mathews II; Ealick SE; Roos DS; Ullman B; Brennan RG
J Mol Biol; 2000 May; 298(5):875-93. PubMed ID: 10801355
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii.
el Kouni MH; Guarcello V; Al Safarjalani ON; Naguib FN
Antimicrob Agents Chemother; 1999 Oct; 43(10):2437-43. PubMed ID: 10508021
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification, and characterization of uracil phosphoribosyltransferase from Toxoplasma gondii.
Carter D; Donald RG; Roos D; Ullman B
Mol Biochem Parasitol; 1997 Aug; 87(2):137-44. PubMed ID: 9247925
[TBL] [Abstract][Full Text] [Related]
13. 6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
Rais RH; Al Safarjalani ON; Yadav V; Guarcello V; Kirk M; Chu CK; Naguib FN; el Kouni MH
Biochem Pharmacol; 2005 May; 69(10):1409-19. PubMed ID: 15857605
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding.
Schumacher MA; Scott DM; Mathews II; Ealick SE; Roos DS; Ullman B; Brennan RG
J Mol Biol; 2000 Feb; 296(2):549-67. PubMed ID: 10669608
[TBL] [Abstract][Full Text] [Related]
15. Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine.
Naguib FN; Rais RH; Al Safarjalani ON; el Kouni MH
Comp Biochem Physiol B Biochem Mol Biol; 2015 Oct; 188():63-9. PubMed ID: 26112826
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological activity and molecular modeling of 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase.
Yadav V; Chu CK; Rais RH; Al Safarjalani ON; Guarcello V; Naguib FN; el Kouni MH
J Med Chem; 2004 Apr; 47(8):1987-96. PubMed ID: 15055998
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.
Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
Biochem Pharmacol; 2007 May; 73(10):1558-72. PubMed ID: 17306769
[TBL] [Abstract][Full Text] [Related]
18. Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei.
Vodnala M; Fijolek A; Rofougaran R; Mosimann M; Mäser P; Hofer A
J Biol Chem; 2008 Feb; 283(9):5380-8. PubMed ID: 18167353
[TBL] [Abstract][Full Text] [Related]
19. Double-stranded RNA specific to adenosine kinase and hypoxanthine-xanthine-guanine-phosphoribosyltransferase retards growth of Toxoplasma gondii.
Yu L; Gao YF; Li X; Qiao ZP; Shen JL
Parasitol Res; 2009 Jan; 104(2):377-83. PubMed ID: 18836745
[TBL] [Abstract][Full Text] [Related]
20. Structure of Toxoplasma gondii adenosine kinase in complex with an ATP analog at 1.1 angstroms resolution.
Zhang Y; El Kouni MH; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):140-5. PubMed ID: 16421444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]